Niagen Bioscience, Inc. — Director's Dealing 2011

Aug 26, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC.OB)
CIK: 0001386570
Period of Report: 2011-08-23

Reporting Person: FROST PHILLIP MD ET AL (N/A)
Reporting Person: Frost Gamma Investments Trust (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-08-23	Common Stock	X	6750002	$0.21	Acquired	14325004	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-08-23	Common Stock Purchase Warrant (right to buy)	$0.21	X	6750002	Disposed	2013-05-20	Common Stock (6750002)	Indirect

Footnotes

F1: Securities held by Frost Gamma Investments Trust of which the Reporting Person is the Trustee and Frost Gamma Limited Partnership ("FGLP") is the sole and exclusive beneficiary. The Reporting Person is one of two limited partners of FGLP. The general partner of FGLP is Frost Gamma, Inc. ("FGI"), and the sole shareholder of FGI is Frost-Nevada Corporation ("FNC"). The Reporting Person is also the sole shareholder of FNC.